The rate of hypertension and dyslipidemia was also lower (75.5% vs. 92.4% and 16.6% vs. 87.1%, respectively), but probably related to poor recording, which contrasts with 71.4% use of statins, and 72.0% use of ACE inhibitors or angiotensin receptor blockers, 33.1% use of calcium channel blockers within the year before index date. The gene discussed is ACE; the disease is Hypertension.